Ratiopharm

Ratiopharm

Ratiopharm is a German pharmaceutical company that specializes in the production and distribution of generic drugs. The company was founded in 1973 by Adolf Merckle, and it has since grown to become one of the largest pharmaceutical companies in Germany. Ratiopharm's products are sold in over 35 countries worldwide.

History

Ratiopharm was established in 1973 by Adolf Merckle, a German entrepreneur who had a vision of making high-quality medications accessible to everyone. The company started with a small team of scientists and pharmacists, and it quickly grew to become a leading player in the German pharmaceutical industry.

In 2010, Ratiopharm was acquired by Teva Pharmaceutical Industries, an Israeli multinational pharmaceutical company. This acquisition has allowed Ratiopharm to expand its reach and offer its products to a larger global audience.

Products

Ratiopharm produces a wide range of generic drugs, including antibiotics, painkillers, antidepressants, and cardiovascular drugs. The company's products are known for their high quality and affordability, which has made them popular among healthcare providers and patients alike.

Ratiopharm's commitment to research and development has also led to the creation of innovative drug delivery systems, such as transdermal patches and orally disintegrating tablets.

Impact

Ratiopharm's mission to provide affordable, high-quality medications has had a significant impact on the global healthcare industry. By offering generic alternatives to brand-name drugs, the company has helped to reduce healthcare costs and increase access to important medications.

In addition, Ratiopharm's innovative drug delivery systems have improved patient compliance and treatment outcomes in various therapeutic areas.

See also

• Pharmaceutical industry in Germany
• Generic drug
• Teva Pharmaceutical Industries